ProQR Therapeutics マネジメント
マネジメント 基準チェック /44
ProQR Therapeuticsの CEO はDaniel de Boerで、 Feb2012年に任命され、 の在任期間は 12.75年です。 の年間総報酬は€ 2.44Mで、 21.5%給与と78.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.68%を直接所有しており、その価値は$ 2.55M 。経営陣と取締役会の平均在任期間はそれぞれ4.8年と6.2年です。
主要情報
Daniel de Boer
最高経営責任者
€2.4m
報酬総額
| CEO給与比率 | 21.5% |
| CEO在任期間 | 12.8yrs |
| CEOの所有権 | 0.7% |
| 経営陣の平均在職期間 | 4.8yrs |
| 取締役会の平均在任期間 | 6.2yrs |
経営陣の近況
Recent updates
There's Reason For Concern Over ProQR Therapeutics N.V.'s (NASDAQ:PRQR) Massive 118% Price Jump
Oct 23
ProQR Therapeutics N.V. (NASDAQ:PRQR) Investors Are Less Pessimistic Than Expected
Jul 15Broker Revenue Forecasts For ProQR Therapeutics N.V. (NASDAQ:PRQR) Are Surging Higher
May 29Is ProQR Therapeutics (NASDAQ:PRQR) Using Too Much Debt?
Apr 03Health Check: How Prudently Does ProQR Therapeutics (NASDAQ:PRQR) Use Debt?
Nov 28Is ProQR Therapeutics (NASDAQ:PRQR) Using Too Much Debt?
Jul 30Despite Lacking Profits ProQR Therapeutics (NASDAQ:PRQR) Seems To Be On Top Of Its Debt
Mar 17ProQR says EU regulator seeks additional trial for lead candidate
Aug 11Here's Why ProQR Therapeutics (NASDAQ:PRQR) Can Manage Its Debt Despite Losing Money
Nov 10Investment Case On ProQR Therapeutics Gets More Enticing
Oct 01ProQR Therapeutics (NASDAQ:PRQR) Has Debt But No Earnings; Should You Worry?
Aug 04ProQR Therapeutics: Looks Interesting Ahead Of Next Year's Pivotal Data
Jun 20It's Unlikely That ProQR Therapeutics N.V.'s (NASDAQ:PRQR) CEO Will See A Huge Pay Rise This Year
May 13ProQR Therapeutics offers a de-risked opportunity: Stifel
May 03If You Had Bought ProQR Therapeutics' (NASDAQ:PRQR) Shares A Year Ago You Would Be Down 42%
Mar 08Could The ProQR Therapeutics N.V. (NASDAQ:PRQR) Ownership Structure Tell Us Something Useful?
Feb 01
ProQR concludes enrollment in mid-stage cell therapy trial in a rare eye disorder
Jan 07ProQR Therapeutics (NASDAQ:PRQR) Has Debt But No Earnings; Should You Worry?
Dec 28A Look At ProQR Therapeutics' (NASDAQ:PRQR) Share Price Returns
Dec 01CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -€24m |
| Jun 30 2024 | n/a | n/a | -€22m |
| Mar 31 2024 | n/a | n/a | -€27m |
| Dec 31 2023 | €2m | €524k | -€28m |
| Sep 30 2023 | n/a | n/a | -€36m |
| Jun 30 2023 | n/a | n/a | -€54m |
| Mar 31 2023 | n/a | n/a | -€59m |
| Dec 31 2022 | €2m | €504k | -€64m |
| Sep 30 2022 | n/a | n/a | -€69m |
| Jun 30 2022 | n/a | n/a | -€61m |
| Mar 31 2022 | n/a | n/a | -€63m |
| Dec 31 2021 | €2m | €449k | -€61m |
| Sep 30 2021 | n/a | n/a | -€57m |
| Jun 30 2021 | n/a | n/a | -€55m |
| Mar 31 2021 | n/a | n/a | -€43m |
| Dec 31 2020 | €3m | €449k | -€47m |
| Sep 30 2020 | n/a | n/a | -€52m |
| Jun 30 2020 | n/a | n/a | -€51m |
| Mar 31 2020 | n/a | n/a | -€58m |
| Dec 31 2019 | €2m | €449k | -€56m |
| Sep 30 2019 | n/a | n/a | -€51m |
| Jun 30 2019 | n/a | n/a | -€45m |
| Mar 31 2019 | n/a | n/a | -€40m |
| Dec 31 2018 | €1m | €445k | -€37m |
| Sep 30 2018 | n/a | n/a | -€35m |
| Jun 30 2018 | n/a | n/a | -€40m |
| Mar 31 2018 | n/a | n/a | -€44m |
| Dec 31 2017 | €1m | €353k | -€44m |
報酬と市場: Danielの 総報酬 ($USD 2.56M ) は、 US市場 ($USD 2.16M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Danielの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Daniel de Boer (41 yo)
12.8yrs
在職期間
€2,439,000
報酬
Mr. Daniel Anton de Boer has been the Chief Executive Officer and Member of Management Board at ProQR Therapeutics N.V. since February 21, 2012. He serves as Member of Strategic Advisory Board at Hybridize...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 12.8yrs | €2.44m | 0.68% $ 2.6m | |
| Founder & Independent Member of Supervisory Board | no data | €150.00k | 0.41% $ 1.5m | |
| Chief Corporate Development Officer | 2.4yrs | €1.31m | 0.45% $ 1.7m | |
| Co-Founder | 12.8yrs | €34.00k | データなし | |
| Chief Financial Officer | 2yrs | データなし | データなし | |
| Chief People & Operations Officer | 4.8yrs | データなし | データなし | |
| Vice President of Investor Relations & Corporate Communications | no data | データなし | データなし | |
| Junior Financial Controller | no data | データなし | データなし |
4.8yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: PRQRの経営陣は 経験豊富 であると考えられます ( 4.8年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder & Independent Member of Supervisory Board | 10.8yrs | €150.00k | 0.41% $ 1.5m | |
| Independent Member of Supervisory Board | 10.2yrs | €126.00k | 0% $ 0 | |
| Member of Scientific Advisory Board | 7.4yrs | データなし | データなし | |
| Supervisory Board Member | 1.5yrs | €271.00k | 0.026% $ 95.9k | |
| Chairman of the Board of Directors & Chairman of Scientific Advisory Board | 4.3yrs | €132.00k | 0.060% $ 222.8k | |
| Member of the Board of Directors | 5.8yrs | €127.00k | 0% $ 0 | |
| Supervisory Board Member & Member of Scientific Advisory Board | 4.3yrs | データなし | データなし | |
| Member Scientific Advisory Board | 6.6yrs | データなし | データなし | |
| Member of Scientific Advisory Board | 6.5yrs | データなし | データなし | |
| Member of the Board of Directors | 1.8yrs | €84.00k | 0% $ 0 |
6.2yrs
平均在職期間
63.5yo
平均年齢
経験豊富なボード: PRQRの 取締役会 は 経験豊富 であると考えられます ( 6.2年の平均在任期間)。